Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Similar documents
Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Epworth Sleepiness Scale (ESS)

Modified Hachinski Ischemic Scale: NACC Version (MHIS-NACC) v.1.0

Hospital Anxiety and Depression Scale (HADS)

Barnes Akathisia Rating Scale (BARS)

Clinical Global Impression (CGI)

Disability Assessment for Dementia (DAD)

Neuropathic Pain Scale (NPS)

Michigan Neuropathy Screening Instrument (MNSI)

Hamilton Depression Rating Scale 17-Item (HAMD 17)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Pain Relief (PR) Notes to Readers

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Short-Form McGill Pain Questionniare-2 (SHORT-FORM MPQ-2)

Timed Up and Go (TUG)

Unified Parkinson's Disease Rating Scale UPDRS

Unified Parkinson's Disease Rating Scale UPDRS

Rating Mental Impairment with AMA Guides 6 th edition:

RATING MENTAL WHOLE PERSON IMPAIRMENT UNDER THE NEW SABS: New Methods, New Challenges. CSME/CAPDA Conference, April 1, 2017

Let s Create Standard Value Level Metadata

OUTCOMES OF DICHOTOMIZING A CONTINUOUS VARIABLE IN THE PSYCHIATRIC EARLY READMISSION PREDICTION MODEL. Ng CG

Clinical Trial Database Analyses to Inform Regulatory Guidances: Improving the Efficiency of Schizophrenia Clinical Trials

Intervention ML: Mapping of Meal data. Rahul Loharkar, inventiv Health Clinical, Pune, India Sandeep Sawant, inventiv Health Clinical, Mumbai, India

BRIEF PSYCHIATRIC RATING SCALE-ANCHORED (BPRS-A) BRIEF PSYCHIATRIC RATING SCALE-ANCHORED (BPRS-A):

BRIEF PSYCHIATRIC RATING SCALE ANCHORED. Introduce all questions with During the past week have you..

BADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0)

Alzheimer s Disease-specific Therapeutic Area Supplement to the Study Data Tabulation Model User Guide

PharmaSUG Paper DS12

Project Charter. Template v2 June 3, February 25, Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards

Wisconsin Quality of Life Provider Questionnaire Wisconsin Quality of Life Associates University of Wisconsin - Madison.

CDISC BrCa TAUG & Oncology Information Session

Neurobehavioural deficits after severe traumatic brain injury (TBI)

CFAST Asthma Project. Rhonda Facile. CDISC International Interchange Session 4B: Therapeutic Area Standards in Action November 6, 2013

How to manage changes to CDISC standards at Novo Nordisk. PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun

Psychopathology in patients with schizophrenia attending a psychiatry outpatient clinic at a tertiary care hospital

Therapeutic Area User Guide Cardiovascular V1.0 Public Review Webinar April 3, 2014

PharmaSUG Paper DS04

Nikolaos Bilanakis 1, Aikaterini Vratsista 1, Georgios Kalampokis 1, Georgios Papamichael 1 and Vaios Peritogiannis 2*

Jerry Salyers, Accenture Accelerated R&D Services Fred Wood, Accenture Accelerated R&D Services. PhUSE 2017 Edinburgh, Scotland Paper #DS05

CDISC Public Webinar- Post Traumatic Stress Disorder Therapeutic Area User Guide

NEUROPSYCHOPHARMACOLOGY 2002 VOL. 26, NO American College of Neuropsychopharmacology

Characteristics of trees drawn by patients with paranoid schizophrenia

Blood Lipids and Behavior in Mental-Hospital Patients

Examples: Tables. Descriptive stats with ANOVA, ANCOVA, and t test p values Frequency and percent Correlation coefficients

THE STABILITY OF SYMPTOMS AND SYNDROMES IN CHRONIC SCHIZOPHRENIC PATIENTS MILIND BORDE 1, ELIZABETH J.B. DAVIS 1 AND L.N. SHARMA 2

EVALUATION OF WORRY IN PATIENTS WITH SCHIZOPHRENIA AND PERSECUTORY DELUSION COMPARED WITH GENERAL POPULATION

Bizarre delusions and DSM-IV schizophrenia

A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups

Catastrophic Impairment:

SACRED HEART HOSPITAL 421 Chew Street Allentown, PA EAC REFERRAL PACKET REQUIREMENTS

Jitsuki Sawamura 1*, Shigeru Morishita 2, Jun Ishigooka 1. Abstract

Residual Functional Capacity Questionnaire MENTAL IMPAIRMENT

CDISC CONTROLLED TERMINOLOGY. Presented by Chris Gemma and Erin Muhlbradt, Ph.D.

Study Endpoint Considerations: Final PRO Guidance and Beyond

Quality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination

CDISC Controlled Terminology. Presented by Chris Gemma and Erin Muhlbradt, Ph.D.

Breast Cancer TAUG Overview and Implementation

Design and Construct Efficacy Analysis Datasets in Late Phase Oncology Studies

The Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data

ZERO SUICIDE DATA ELEMENTS WORKSHEET

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Robin Feldman, MBA & Joy Esterlitz, MS NINDS CDE Team The Emmes Corporation Rockville, MD USA. Thursday, September 14, 2017

CDISC - Mapping New Pathways for Novartis. Darren Weston, Project Leader Pat Majcher, Senior Principal Programmer

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Supplementary Online Content

How do we diagnose psychological disorders? Class Objectives 1/21/2009. What is Clinical Assessment? Chapter 3- Clinical Assessment and Diagnosis

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Neuropsychopharmacology Unit, Division of Experimental Medicine, Imperial College, Hammersmith Hospital, 160 Du Cane Road, W129LL, London, UK

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

1 IN 5 PATIENTS MAY HARBOR DIAGNOSABLE MENTAL ILLNESS 1 LabCorp can help you identify the patients that can benefit from treatment

Clinical Review Report (Sample)

Goal: To recognize and differentiate different forms of psychopathology that involve disordered thinking and reasoning and distorted perception

How to - Trial Summary Parameter. CJUG SDTM Team : LISaS

A Robust Recursive Partitioning Algorithm for Mining Multiple Populations

PharmaSUG 2018 Paper AD-02

Measure #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination

BASIS-Teen Pilot Project

A PSYCHIATRIC RATING SCALE FOR SCHIZOPHRENIA IN SINGAPORE (WOODBRIDGE HOSPITAL RATING SCALE FOR SCHIZOPHRENIA)

Psychosis, Mood, and Personality: A Clinical Perspective

CDISC SHARE. CDISC Shared Health and Research Electronic Library Pilot Report. Date: 19 January 2010 Version: 1.0 CDISC, 2010

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Clinical Skills Verification Form CSV.3

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety

University of Perugia, Perugia, Italy 3 Faculty of Medicine and Surgery, Medical School, University of Perugia, Perugia, Italy

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Clinical Study Utility of Two PANSS 5-Factor Models for Assessing Psychosocial Outcomes in Clinical Programs for Persons with Schizophrenia

SDTMIG v3.3 Batch 2 Upcoming Public Review. Presented by Fred Wood

CHILD AND ADOLESCENT ISSUES BEHAVIORAL HEALTH. SAP K-12 Bridge Training Module for Standard 4 Section 3: Behavioral Health & Observable Behaviors

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Delusional Disorder Websites Reviewed by Todd Gibbs. Wikipedia s introductory paragraph describes the general diagnostic criteria for

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #414: Evaluation or Interview for Risk of Opioid Misuse National Quality Strategy Domain: Effective Clinical Care

IAASB Main Agenda (March 2005) Page Agenda Item. DRAFT EXPLANATORY MEMORANDUM ISA 701 and ISA 702 Exposure Drafts February 2005

Transcription:

Brief Psychiatric Rating Scale-Anchored (BPRS-A) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC Questionnaire Sub-team Notes to Readers This implementation guide is intended to be used with other CDISC User Guides for specific Therapeutic/Disease Areas and follows the CDISC Study Data Tabulation Model Implementation Guide for Human Clinical trials. Revision History Date Version Summary of Changes 2012-12-12 0.1 Brief Psychiatric Rating Scale (BPRS-A) Draft 2013-01-29 1.0 Brief Psychiatric Rating Scale (BPRS-A)

1 Introduction This document describes the CDISC implementation of the Brief Psychiatric Rating Scale- Anchored (BPRS-Anchored or BPRS-A) questionnaire, a standard questionnaire that is typically used in clinical trials to provide an assessment of psychopathology. The BPRS-A questionnaire preceded the CDISC CDASH CRF standards and based on its public domain status, cannot be modified to CDASH standards. The annotated CRF that accompanies this implementation guide was transcribed from the BPRS-A reference article, although some header information has been omitted (i.e. Pt. Name and Rater) and form completion instructions have been added (i.e. INSTRUCTIONS: Indicate the appropriate scale point for each item by marking X in the appropriate numbered box. Do not leave any items blank.). The annotated CRF is supplied only to illustrate how the questionnaire items map to SDTM and is not intended to serve as the data collection instrument for sponsors. The representation of data collected for this questionnaire is based on the Study Data Tabulation Model Implementation Guide (SDTMIG) QS domain table, which can be found at the CDISC website at: (http://www.cdisc.org/sdtm). These specific implementation details for this questionnaire are meant to be used in conjunction with the SDTMIG. All questionnaire documentation can be found on the CDISC web site at: (http://www.cdisc.org/content2909). The CDISC Intellectual Property Policy can be found on the CDISC web site at: (http://www.cdisc.org/bylaws-and-policies). 1.1 Representations and Warranties, Limitations of Liability, and Disclaimers This document is a supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material. 2 Copyright Status This instrument is in the public domain. CDISC has included the Brief Psychiatric Rating Scale- Anchored (BPRS-A) as part of CDISC Data Standards. This means that CDISC developed QSTESTCD and QSTEST for each question based on the actual question text on the questionnaire. There may be many versions of this questionnaire in the public domain. CDISC has chosen to use this version as the data standard. The CDISC documentation of this instrument consists of: (1) controlled terminology, (2) standard database structure with examples, and (3) case report forms annotated with the CDISC SDTMIG submission values. Note: CDISC controlled terminology is maintained by NCI EVS. The most recent version should be accessed through the CDISC website. (http://www.cdisc.org/terminology) 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 2

CDISC has developed this documentation at no cost to users of the instrument. 3 The QS Domain Model 3.1 Assumptions for Questionnaire Domain Model All assumptions for the QS domain from the SDTMIG apply for this supplemental implementation guide including those referenced in the CDISC notes. Additionally, the following assumptions apply to the Brief Psychiatric Rating Scale-Anchored form: 1. Brief Psychiatric Rating Scale-Anchored (BPRS-A): BPRS-A is a multiple choice questionnaire that clinicians may use to provide an assessment of psychopathology. It consists of 18 items, each rated on a 7-point scale. Ratings are made during a brief (15-20 min), semi-structured interview with the subject. 2. The scale points include a rating (e.g. Mild ) and a definition of what is represented by the rating (e.g. occasionally feels moderately depressed, or often feels somewhat depressed ). For BPRS-A, QSORRES is populated with the rating only. The rating definition is considered as just a reference for the evaluator to use in assigning a rating and is not submitted in SDTM. 3. For some items, the BPRS-A questionnaire has a choice of 9 = Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or Not assessed. This is considered a Not Done response (QSSTAT = NOT DONE ) with the reference text considered the reason for the Not Done response (QSREASND = CANNOT BE ASSESSED ADEQUATELY BECAUSE OF SEVERE FORMAL THOUGHT DISORDER, UNCOOPERATIVENESS, OR MARKED EVASIVENESS/GUARDEDNESS; OR NOT ASSESSED ). The numeric rating of 9 is not considered a score for this questionnaire, is not used in calculating any summary statistics, and is therefore not placed in SDTM. 4. The time period of evaluation for the BPRS-A is populated in the QSEVLINT field in ISO 8601 format when the evaluation interval can be precisely described as duration. Typically, the evaluation interval for BPRS-A is the past week. 5. The questionnaire rater s role should be stored in QSEVAL. For BPRS-A, the rater is usually defined as INVESTIGATOR. Additional identifying information to further distinguish the rater in QSEVAL should be stored in QSEVALID. An example is rater initials. 6. Terminology: a. QSCAT, QSTESTCD and QSTEST are approved CDISC controlled terminology. b. A full list of value sets for QSORRES, QSSTRESC and QSSTRESN fields is provided in Section 4: SDTM Mapping Strategy. 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 3

3.2 Example for Brief Psychiatric Rating Scale-Anchored QS Domain Model The BPRS-A example below shows the terminology for QSCAT, QSTEST, QSTESTCD and the standardized values for QSORRES, QSSTRESC, QSSTRESN and QSEVAL that should be utilized for this scale. 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 4

Example: Brief Psychiatric Rating Scale-Anchored (BPRS-A) This example shows data from one subject collected at one visit for a BPRS-A questionnaire. This example is based on a questionnaire with an evaluation interval of the past week. Rows 1-18: Represent the questions from the BPRS-A form. All original results are represented with preferred terminology in QSORRES. This result is then transformed into a standard numeric score in QSSTRESN and a character representation of the standard numeric score in QSSTRESC. QSBLFL is NULL, since this example only shows the questionnaire results for visit 2. Row 5 shows a case where the rating for a specific item was noted as Cannot be assessed adequately because of severe formal thought disorder, uncooperativeness, or marked evasiveness/guardedness; or Not assessed. This is considered a not done record and the item rating is considered as the reason not done (QSREASND). qs.xpt Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSORRES QSSTRESC QSSTRESN 1 STUDYX QS P0001 1 BPR0101 BPR01-Somatic Concern BPRS-A VERY MILD 2 2 2 STUDYX QS P0001 2 BPR0102 BPR01-Anxiety BPRS-A MILD 3 3 3 STUDYX QS P0001 3 BPR0103 BPR01-Emotional Withdrawal BPRS-A VERY MILD 2 2 4 STUDYX QS P0001 4 BPR0104 BPR01-Conceptual Disorganization BPRS-A NOT OBSERVED 1 1 5 STUDYX QS P0001 5 BPR0105 BPR01-Guilt Feelings BPRS-A 6 STUDYX QS P0001 6 BPR0106 BPR01-Tension BPRS-A MILD 3 3 7 STUDYX QS P0001 7 BPR0107 BPR01-Mannerisms and Posturing BPRS-A SEVERE 6 6 8 STUDYX QS P0001 8 BPR0108 BPR01-Grandiosity BPRS-A VERY MILD 2 2 9 STUDYX QS P0001 9 BPR0109 BPR01-Depressive Mood BPRS-A MILD 3 3 10 STUDYX QS P0001 10 BPR0110 BPR01-Hostility BPRS-A NOT REPORTED 1 1 11 STUDYX QS P0001 11 BPR0111 BPR01-Suspiciousness BPRS-A VERY MILD 2 2 12 STUDYX QS P0001 12 BPR0112 BPR01-Hallucinatory Behavior BPRS-A VERY MILD 2 2 13 STUDYX QS P0001 13 BPR0113 BPR01-Motor Retardation BPRS-A MODERATE 4 4 14 STUDYX QS P0001 14 BPR0114 BPR01-Uncooperativeness BPRS-A NOT OBSERVED 1 1 15 STUDYX QS P0001 15 BPR0115 BPR01-Unusual Thought Content BPRS-A MILD 3 3 16 STUDYX QS P0001 16 BPR0116 BPR01-Blunted Affect BPRS-A MODERATE 4 4 17 STUDYX QS P0001 17 BPR0117 BPR01-Excitement BPRS-A MODERATE 4 4 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 5

18 STUDYX QS P0001 18 BPR0118 BPR01-Disorientation BPRS-A VERY SEVERE 7 7 Row QSSTAT QSREASND QSBLFL QSEVAL QSEVALID VISITNUM QSDTC QSEVLINT 1 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 2 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 3 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 4 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 5 (cont) NOT DONE CANNOT BE ASSESSED ADEQUATELY INVESTIGATOR GEC 2 2012-11-16 -P1W BECAUSE OF SEVERE FORMAL THOUGHT DISORDER, UNCOOPERATIVENESS, OR MARKED EVASIVENESS/GUARDEDNESS; OR NOT ASSESSED 6 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 7 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 8 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 9 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 10 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 11 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 12 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 13 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 14 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 15 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 16 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 17 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 18 (cont) INVESTIGATOR GEC 2 2012-11-16 -P1W 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 6

4 SDTM Mapping Strategy BPRS-A specific mapping strategy: This section is used for reference with the annotated CRF for further details on the CRF data capture and to understand the alignment of the questionnaire to the SDTM QS domain. It also provides guidance on how the result variables (QSORRES, QSSTRESC, and QSSTRESN) should be populated for the questionnaire. QSTESTCD=BPR0101 QSTEST= BPR01-Somatic Concern QSTESTCD=BPR0102 QSTEST= BPR01-Anxiety QSTESTCD=BPR0105 QSTEST= BPR01-Guilt Feelings QSTESTCD=BPR0108 QSTEST= BPR01-Grandiosity QSTESTCD=BPR0109 QSTEST= BPR01-Depressive Mood QSTESTCD=BPR0110 QSTEST= BPR01-Hostility QSTESTCD=BPR0111 QSTEST= BPR01-Suspiciousness QSTESTCD=BPR0112 QSTEST= BPR01-Hallucinatory Behavior QSTESTCD=BPR0115 QSTEST= BPR01-Unusual Thought Content QSORRES QSSTRESC QSSTRESN NOT REPORTED 1 1 VERY MILD 2 2 MILD 3 3 MODERATE 4 4 MODERATELY SEVERE 5 5 SEVERE 6 6 VERY SEVERE 7 7 QSTESTCD=BPR0103 QSTEST= BPR01-Emotional Withdrawal QSTESTCD=BPR0104 QSTEST= BPR01-Conceptual Disorganization QSTESTCD=BPR0106 QSTEST= BPR01-Tension QSTESTCD=BPR0107 QSTEST= BPR01-Mannerisms and Posturing QSTESTCD=BPR0113 QSTEST= BPR01-Motor Retardation QSTESTCD=BPR0114 QSTEST= BPR01-Uncooperativeness QSTESTCD=BPR0116 QSTEST= BPR01-Blunted Affect QSTESTCD=BPR0117 QSTEST= BPR01-Excitement QSTESTCD=BPR0118 QSTEST= BPR01-Disorientation QSORRES QSSTRESC QSSTRESN NOT OBSERVED 1 1 VERY MILD 2 2 MILD 3 3 MODERATE 4 4 MODERATELY SEVERE 5 5 SEVERE 6 6 VERY SEVERE 7 7 End of Document 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 7